Search Results - "Tarabanovskaya, N. A."

Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy by Patysheva, M. R., Stakheyeva, M. N., Grigoryeva, E. S., Iamshchikov, P. S., Larionova, I. V., Budnickya, А. A., Tarabanovskaya, N. A., Cherdyntseva, N. V., Kzhyshkowska, J. G.

“…Introduction. Chemotherapy is a common treatment for breast cancer. Chemotherapeutic drugs effect blood monocytes, which are major contributors to cancer…”
Get full text

Combination of pregnancy and breast cancer by Chernyshova, A. L., Chernyakov, A. A., Garbukov, E. Yu, Tarabanovskaya, N. A., Trushchuk, Yu. M., Dil, O. S., Krasilnikov, S. E., Shumeykina, A. V.

“…Breast cancer (BC) occupies the second place in terms of incidence and the first ranking place in terms of mortality among oncopathology in women. The article…”
Get full text

Role of proteasome system in prognosis of breast cancer progression by Shashova, E. E., Tarabanovskaya, N. A., Bondar, L. N.

“…The aim of this study was to compare the activity of proteasomes with different variants of tumor progression in luminal and triple-negative breast cancer…”
Get full text

THE PRESENCE OF VARIOUS POPULATIONS OF CIRCULATING TUMOR CELLS IN THE BLOOD OF BREAST CANCER PATIENTS BEFORE TREATMENT: ASSOCIATION WITH FIVE-YEAR METASTASIS-FREE SURVIVAL by Kaigorodova, E. V., Tarabanovskaya, N. A., Surkova, P. V., Zelchan, R. V., Garbukov, E. Yu

“…Localized and metastatic tumors are known to lead to the formation of circulating tumor cell (CTC ) clusters in the blood. Currently, there is a heightened…”
Get full text

Monocytes and cancer: promising role as a diagnostic marker and application in therapy by Patysheva, M. R., Stakheeva, M. N., Larionova, I. V., Tarabanovskaya, N. A., Grigorieva, E. S., Slonimskaya, E. M., Kzhyshkowska, J. G., Cherdyntseva, N. V.

“…  Interrelationship between a malignant tumor and the immunity are provided by the involvement of both adaptive and innate immune systems. Monocytes are major…”
Get full text

Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer by Slonimskaya, E. M., Doroshenko, A. V., Kazantseva, P. V., Tarabanovskaya, N. A., Vernadsky, R. Yu

“…Adjuvant hormone therapy is considered the gold standard of therapy for hormone receptor-positive operable breast cancer. The approach to adjuvant hormone…”
Get full text

RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR by Tsyganov, M. M., Tarabanovskaya, N. A., Deryusheva, I. V., Ibragimova, M. K., Kazantseva, P. V., Pevzner, A. M., Slonimskaya, E. M., Litviakov, N. V.

“…Currently, the presence of the germinal mutation BRCA1 5382insC in breast cancer patients is one of the determining factors for prescribing platinum-based…”
Get full text

The clinical observation of human papillomavirus positive breast tumor by Ibragimova, M. K., Tsyganov, M. M., Tarabanovskaya, N. A., Tashireva, L. A., Deryusheva, I. V., Perelmuter, V. M., Slonimskaya, E. M., Litviakov, N. V.

“…In this manuscript, a unique case of HPV16-positive breast cancer is examined. The presence of HPV infection in the tumor is confirmed by two independent…”
Get full text

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER by Slonimskaya, E. M., Tarabanovskaya, N. A., Doroshenko, A. V., Patalyak, S. V.

“…The present study was undertaken to determine the relationship between tumor response to neoadjuvant chemotherapy including capecitabine and long-term…”
Get full text

TEN-YEAR OUTCOMES AFTER BREAST-CONSERVING SURGERY WITH INTRAOPERATIVE RADIOTHERAPY FOR BREAST CANCER by Doroshenko, A. V., Slonimskaya, E. M., Startseva, Zh. A., Lisin, V. A., Garbukov, Ye. Yu, Tarabanovskaya, N. A., Kokorina, Yu. L., Litviakov, N. V.

“…The purpose of the study was to analyze the 10-year outcomes after breast-conserving surgery with electronbeam intraoperative radiation therapy (IORT) followed…”
Get full text

CYTOKINE GENE EXPRESSION ASSOCIATED WITH TUMOR AND PREMETASTATIC NICHES IN BREAST CANCER STROMA by Tashireva, L. A., Geraschenko, T. S., Zavyalova, M. V., Saveleva, O. E., Kaygorodova, E. V., Tarabanovskaya, N. A., Slonimskaya, E. M., Denisov, E. V., Perelmuter, V. M.

“…The tumor niche in the microenvironment of the primary tumor is believed to reflect events occurring in the premetastatic niche. In our study, based on the…”
Get full text

2002PCXCR4, CCR2 and CCR5 expression in subsets of tumor cells with stem and/or EMT features by Savelieva, O E, Tashireva, L A, Kaigorodova, E V, Tarabanovskaya, N A, Perelmuter, V M

“…Abstract Background Numerous investigations have been focused on the role of CXCR4, CCR2 and CCR5 in solid tumors, including breast cancer. These chemokine…”
Get full text

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS by E. V. Kaigorodova, M. V. Bogatyuk, M. V. Zavyalova, N. A. Tarabanovskaya, E. I. Simolina, E. M. Slonimskaya, E. L. Choynzonov, V. M. Perelmuter

“…New and original values (coefficient of phosphorylation and coefficient of intracellular distribution) proposed. They are reflecting a functional state of the…”
Get full text

Opyt primeneniya kapetsitabina v neoad\"yuvantnoy khimioterapii raka molochnoy zhelezy by E M Slonimskaya, N A Tarabanovskaya, O D Bragina, E Yu Garbukov, A V Doroshenko, Yu L Kokorina, M V Zav'yalova

Get full text